Neuropathic in the Acute Post Operative Phase

This study has been terminated.
(recruitment problems)
Sponsor:
Collaborators:
Section for Surgical Pathophysiology
Section of Acute Pain Management and Palliative Medicine
Multidisciplinary Pain Centre
Innovative Medicines Initiative
Information provided by:
Rigshospitalet, Denmark
ClinicalTrials.gov Identifier:
NCT01300702
First received: February 22, 2011
Last updated: September 28, 2011
Last verified: September 2011
  Purpose

Investigation of thermal thresholds and sensory mapping to thermal stimuli


Condition
Lung Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Identification of Neuropathic Pain in the Acute Post Operative Phase Following Thoracotomy

Resource links provided by NLM:


Further study details as provided by Rigshospitalet, Denmark:

Primary Outcome Measures:
  • Pain [ Time Frame: 14 days ] [ Designated as safety issue: No ]
    pain intensity

  • quantitative sensory testing (QST) [ Time Frame: 14 days ] [ Designated as safety issue: No ]
    thermal thresholds assesses via QST

  • Neuropathic pain [ Time Frame: 14 days ] [ Designated as safety issue: No ]
    is the pain considered neuropathic


Enrollment: 0
Study Start Date: February 2011
Study Completion Date: September 2011
Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
lung cancer surgery
Patients undergoing thoracotomy for lung cancer

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Lung cancer patients undergoing thoracotomy

Criteria

Inclusion Criteria:

  • age > 18 years old

Exclusion Criteria:

  • do not under stand Danish
  • cognitive reduction
  • previous thoracic surgery
  • Pregnant or nursing
  • inability to cooperate to pain scoring
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01300702

Locations
Denmark
Rigshospitalet
Copenhagen, Denmark, 2100
Section for Surgical Pathophysiology 4074
Copenhagen, Denmark, 2100
Sponsors and Collaborators
Rigshospitalet, Denmark
Section for Surgical Pathophysiology
Section of Acute Pain Management and Palliative Medicine
Multidisciplinary Pain Centre
Innovative Medicines Initiative
Investigators
Study Chair: Henrik Kehlet, MD Section for Surgical Pathophysiology
Principal Investigator: Kim Wildgaard, MD Section for Surgical Pathophysiology
  More Information

No publications provided

Responsible Party: MD, Kim Wildgaard, Section for Surgical Pathophysiology 4074
ClinicalTrials.gov Identifier: NCT01300702     History of Changes
Other Study ID Numbers: H4-2010-118#1
Study First Received: February 22, 2011
Last Updated: September 28, 2011
Health Authority: Denmark: National Board of Health

ClinicalTrials.gov processed this record on October 20, 2014